Study Condition(s): Parkinson's Disease
A Study of LY3154207 in Participants With Parkinson's Disease (Part B)
Study Alias: HBEC
The purpose of part B of this study will evaluate how safe LY3154207 is and the effect it has on the body.
The results of this study are not yet available.
Here you can find out a bit more about the requirements for volunteers who took part in this study
Part B participant must have a clinical diagnosis of Parkinson's disease for at least 1 year and be on stable medication for at least 4 weeks
Part B participant must be reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Part B participant must not have participated in a clinical trial involving an investigational product within the last 30 days
Part B participant must provide written informed consent